China SXT Pharmaceuticals...

NASDAQ: SXTC · Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 2:17 PM

China SXT Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
5.8M 1.35M -3.1M -8.62M -14.14M -10.04M -5.93M -6.36M -5.46M -7.81M -8.6M -10.09M -10.83M -6.36M -4.12M -7.93M -9.84M -13.57M
Depreciation & Amortization
337.55K 416.79K 389.67K 369.48K 349.3K 246.55K 250.16K 314.07K 310.98K 441.99K 480.01K 508.49K 522.73K 519.66K 518.12K 553.93K 571.83K 522.45K
Stock-Based Compensation
352.1K 352.1K 352.1K 314.69K 277.29K 415.93K 554.57K 1.42M 2.29M 2.31M 2.33M 1.33M 325.78K 162.89K n/a n/a n/a n/a
Other Working Capital
-279.34K -60.74K 157.85K 286K 414.15K 235.44K 56.72K -1.19M -1.81M 234.63K 1.24M 2.31M 2.93M 857.23K -311.64K 2.63M 3.96M 2.71M
Other Non-Cash Items
-7.45M -3.39M 782.58K 6.23M 11.68M 7.73M 3.67M 6.07M 5.49M 4.28M 3.72M 1.55M 1.58M 5.73M 6.08M 11.36M 13.96M 12.73M
Deferred Income Tax
n/a n/a n/a 750.5K -95.35K -258.86K -258.86K -1.01M -161.15K 328.15K 328.15K 41.62K 41.62K -192.68K -192.68K -10.24K -10.24K -101.72K
Change in Working Capital
-1.74M -1.05M -353.87K 681.58K 1.72M 1.55M 1.38M -240.27K -1.37M 1.46M 2.88M 4.62M 5.53M 287.66K -2.15M 521.21K 1.78M 2.89M
Operating Cash Flow
-2.71M -2.32M -1.93M -1.02M -111.2K -95.98K -80.76K 265.7K 321.84K 284.05K 402.44K -1.16M -1.94M -1.96M -1.97M 2.03M 4M 2.47M
Capital Expenditures
-7.06K -7.06K -7.06K -28.82K -50.57K -60.63K -70.68K -86.75K -82.14K -93.22K -93.73K -26.21K 7.55K -90.53K -139.57K -198.68K -228.23K -482.74K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -8.85M -8.85M -8.85M -8.85M -1.48M -1.48M -5.09M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.86M -2.86M n/a n/a 2.86M 2.86M n/a
Other Investing Acitivies
54.39K 43.94K 33.49K 26.04K 18.59K 38.49K 58.38K 9.36M 14M 4.69M 23.37K -6.14M -15.07M -4.36M 1.71M 72.39K 4.37M 1.44M
Investing Cash Flow
47.33K 36.88K 26.42K -2.77K -31.97K -22.14K -12.3K 9.27M 13.92M 4.6M -70.36K -17.87M -26.77M -14.73M -8.71M -173.55K 4.09M -4.13M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.07M 3.23M -2.62M 3.46M 9.55M 6.25M 2.94M 1.44M -2.81M -1.19M 2.39M 9.02M 12.34M 16.52M 18.61M 2.53M -5.49M -2.3M
Financial Cash Flow
9.07M 3.23M -2.62M 3.46M 9.55M 6.25M 2.94M 1.44M -2.81M -1.19M 2.39M 9.02M 12.34M 16.52M 18.61M 2.53M -5.49M 992.15K
Net Cash Flow
612.17K -5.29M -8.24M 5.84M 9.74M 3.06M -282.75K 868.11K 4.42M 3.69M 3.32M -9.22M -15.48M 910.86K 9.11M 5.14M 3.12M -728.34K
Free Cash Flow
-2.71M -2.32M -1.94M -1.05M -161.77K -156.6K -151.44K 178.95K 239.7K 190.83K 308.71K -1.19M -1.94M -2.05M -2.11M 1.83M 3.77M 1.99M